We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Commentary · December 22, 2020

Atezolizumab in Metastatic TNBC: IMpassion130 and 131 Trials



Additional Info

Disclosure statements are available on the authors' profiles:

Atezolizumab in Metastatic Triple-Negative Breast Cancer: IMpassion130 and 131 Trials – How to Explain Different Results?
ESMO Open 2020 Nov 01;5(6)1-4, MA Franzoi, E de Azambuja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading